SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-009751
Filing Date
2023-02-09
Accepted
2023-02-09 16:05:18
Documents
2
Period of Report
2023-02-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1564
2 POWER OF ATTORNEY ea172703ex24-1_citius.htm EX-24.1 5811
  Complete submission text file 0001213900-23-009751.txt   8926
Mailing Address C/O PAVMED INC. ONE GRAND CENTRAL PLACE, STE. 4600 NEW YORK NY 10165
Business Address
MCGRATH DENNIS M (Reporting) CIK: 0001269340 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38174 | Film No.: 23606181

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations